Antiandrogens affect existing facial hair only slightly; patients may see slower growth and some reduction in density and coverage. The most significant cardiovascular risk for transgender women is the prothrombotic effect increased blood clotting of estrogens. Br J Urol. Especially in the early stages of feminizing hormone therapy, blood work is done frequently to assess hormone levels and liver function. De Groot 18 May Ann Pharmacother. Furthermore, it will be studied whether age, weight change, body mass index BMIsmoking, treatment regimen, or serum hormone levels influence breast development.
Physiology, Pathophysiology, and Clinical Management.
Building muscle takes more work. Can J Psychiatry. A review concluded that hormone therapy for transgender people is safe when supervised by a qualified medical professional.
Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism.